search button
Open Access

[Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin

  • Authors:
    • Hang Tian
    • Lei Hou
    • Yu-Mei Xiong
    • Jun-Xiang Huang
    • Ying-Jun She
    • Xiao-Bao Bi
    • Xing-Rong Song

  • View Affiliations

  • Published online on: January 17, 2022     https://doi.org/10.3892/or.2022.8265
  • Article Number: 54

  • Copyright : © Tian et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

March-2022
Volume 47 Issue 3

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.8
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.5
  • CiteScore Rank: Q1: #74/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.719
  • SCImago Journal Rank (SJR): 0.864
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Tian H, Hou L, Xiong Y, Huang J, She Y, Bi X and Song X: [Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin. Oncol Rep 47: 54, 2022.
APA
Tian, H., Hou, L., Xiong, Y., Huang, J., She, Y., Bi, X., & Song, X. (2022). [Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin. Oncology Reports, 47, 54. https://doi.org/10.3892/or.2022.8265
MLA
Tian, H., Hou, L., Xiong, Y., Huang, J., She, Y., Bi, X., Song, X."[Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin". Oncology Reports 47.3 (2022): 54.
Chicago
Tian, H., Hou, L., Xiong, Y., Huang, J., She, Y., Bi, X., Song, X."[Retracted] miR‑218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin". Oncology Reports 47, no. 3 (2022): 54. https://doi.org/10.3892/or.2022.8265